Analysis
The R&D Tax Bill Nobody Voted For: Surviving Section 174 Capitalization in the First Full Filing Season
For the first time, businesses are filing returns under mandatory capitalization of research and experimental costs. Companies that spent nothing new on research can owe substantially more tax than they did a year ago. The change was enacted in 2017 and deferred until now, which means it arrives this filing season with full force and without the legislative fix many assumed would come. This is the most consequential cost-recovery change most research-intensive businesses will face this year, and the planning response is overdue rather than early.
What changed, and why it lands now
The Tax Cuts and Jobs Act (TCJA), Pub. L. 115-97, amended IRC § 174 in § 13206. The amendment ended immediate deduction of specified research and experimental (R&E) expenditures and required them to be capitalized and amortized instead.
The provision was written with a delayed effective date. It applies to amounts paid or incurred in taxable years beginning after December 31, 2021. For calendar-year taxpayers, that means tax year 2022 — the returns being filed right now. The deferral is why a 2017 law is a 2023 problem.
Under amended § 174, domestic R&E is amortized over five years and foreign R&E over fifteen. Because amortization begins at the midpoint of the year under a half-year convention, the first-year deduction is roughly 10 percent of domestic R&E and roughly 3.33 percent of foreign R&E. The remainder is spread across the following years.
Software development is swept in directly. Amounts paid or incurred in connection with the development of software are treated as specified R&E expenditures under § 174(c)(3), which means the rule reaches well beyond traditional laboratory research into ordinary product engineering.
The cash-tax problem nobody budgeted for
The defining feature of this change is that it raises taxable income without any change in what a business actually does. A company that spent the same amount on research as it did last year now deducts only a fraction of it.
Consider a profitable business with $250,000 of domestic R&E. Under prior law, the full $250,000 was deductible in the year incurred. Under amended § 174, only about $25,000 is deductible in the first year. Taxable income rises by roughly $225,000 with no new spending and no increase in economic profit. For a business that lives near the edge of its cash position — a startup, a software company, a venture still scaling — the result can be a tax bill that bears no relationship to cash actually in the bank.
This is the phantom-income effect. The deductions are not lost; they reverse over the amortization period. But the timing mismatch is real, and for some businesses it is acute.
The downstream effects are larger than the headline
Capitalizing R&E does not stop at the § 174 line. Because it increases taxable income, it cascades into other calculations.
It interacts with the business-interest limitation under § 163(j), which for tax years beginning after 2021 is computed on a tighter base. It interacts with state taxes, because many states do not conform to the federal § 174 change and must be analyzed individually. And it raises estimated-tax obligations for the current year, which is where the cash-flow strain often first becomes visible.
A business that models only the federal § 174 deduction in isolation will understate the full effect on its position.
How the change is made on the return
Adopting the amended § 174 method is treated as a change in method of accounting. For the first taxable year beginning after December 31, 2021, the change is made on a cut-off basis — there is no § 481(a) adjustment for prior years — by attaching a statement in lieu of a Form 3115 to the return. The operative procedure for these returns is Rev. Proc. 2023-11.
The procedure carries a timing incentive that is easy to miss: a taxpayer that adopts the method on its first affected return receives audit protection, while a taxpayer that waits until a later year does not. The path of least resistance — defer the problem — is the more exposed path.
The questions that remain open
It would be convenient to report that the scope of § 174 is fully settled. It is not.
As of this filing season, several questions lack authoritative guidance. How far capitalization reaches into indirect, overhead, and general-and-administrative costs is unresolved. The treatment of contract research — which party capitalizes, and when — is unresolved. The precise boundary of "software development" is undefined. These are not academic edges; they affect the dollar figure on the return.
Where the law is genuinely unsettled, the defensible course is a consistent, well-documented position that can be explained and supported, not an aggressive reading that maximizes the current deduction and invites later challenge. The standard is a position built to hold if the guidance, when it arrives, lands differently than hoped.
What this means in practice
Do not file on the assumption of a legislative repeal. There is no enacted relief, and a return cannot be built on a bill that has not passed. Identify and quantify R&E spend now, model the cash-tax and estimated-tax effect including the § 163(j) and state interactions, adopt the method change on this return to preserve audit protection, and document the cost-allocation positions taken in the areas guidance has not yet reached.
Key takeaways
- For tax years beginning after December 31, 2021, IRC § 174 (as amended by TCJA § 13206) requires capitalizing and amortizing research and experimental expenditures over five years (domestic) or fifteen years (foreign), ending immediate expensing.
- Because amortization begins at the midpoint of the year, only about 10 percent of domestic R&E is deductible in the first year.
- Software development costs are treated as specified R&E and must be capitalized under § 174(c)(3).
- The change raises taxable income with no new spending — the phantom-income effect — and cascades into § 163(j), state taxes, and estimated payments.
- The method change is made on a cut-off basis under Rev. Proc. 2023-11, and adopting it on the first affected return preserves audit protection.
Frequently asked questions
Does Section 174 only affect companies with formal research departments?
No. Because software development is treated as specified research and experimental expenditure under § 174(c)(3), the rule reaches ordinary product engineering at software and technology companies, not just traditional laboratory research.
Why does my tax bill go up if I did not spend more on research?
Amended § 174 spreads a previously immediate deduction over five or fifteen years. A company that spends the same amount as last year deducts only a fraction of it this year, so taxable income rises even though economic profit and cash spending have not changed.
Should I wait for Congress to fix this before filing?
No. As of this filing season, no relief has been enacted. A return must be prepared under current law, and adopting the method change now also preserves audit protection that a later adoption would forfeit.
How is the change reported?
For the first taxable year beginning after December 31, 2021, the accounting-method change is made on a cut-off basis with a statement in lieu of Form 3115, under Rev. Proc. 2023-11.
Related insights
- Analysis · May 2026 · 4 min read"No Tax on Tips" Is Now Final: What the April 2026 Regulations Settle for Employers
- Tax Alert · April 2026 · 9 min readThe 1% Remittance Transfer Tax: Cash and Money-Order Transfers Are Taxed, Electronic Transfers Are Not
- Analysis · February 2026 · 4 min readDomestic R&D Is Deductible Again — and the Catch-Up Window Closes July 6, 2026
Where this connects
Start Here
Weighing a decision this touches?
If this development maps to your position, the next step is a focused conversation. We define the issue and the timeline before recommending scope.
We typically respond within one business day.